לפונקס 25 מ"ג טבליות

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

CLOZAPINE 25 MG

Disponible desde:

NOVARTIS PHARMA SERVICES AG

Código ATC:

N05AH02

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricado por:

NOVARTIS PHARMACEUTICALS LTD, UK

Grupo terapéutico:

CLOZAPINE

indicaciones terapéuticas:

Treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for death.

Fecha de autorización:

2012-10-01